Societal CDMO (SCTL) Revenue & Revenue Breakdown
Societal CDMO Revenue Highlights
Latest Revenue (Y)
$94.64M
Latest Revenue (Q)
$27.72M
Societal CDMO Revenue by Period
Societal CDMO Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $94.64M | 4.90% |
| 2022-12-31 | $90.21M | 19.71% |
| 2021-12-31 | $75.36M | 13.33% |
| 2020-12-31 | $66.50M | -32.98% |
| 2019-12-31 | $99.22M | 28.28% |
| 2018-12-31 | $77.35M | 7.67% |
| 2017-12-31 | $71.83M | 3.60% |
| 2016-12-31 | $69.34M | 33.46% |
| 2015-12-31 | $51.95M | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | - |
Societal CDMO generated $94.64M in revenue during NA 2023, up 4.90% compared to the previous quarter, and up 122.35% compared to the same period a year ago.
Societal CDMO Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $27.72M | 17.50% |
| 2023-09-30 | $23.59M | 8.22% |
| 2023-06-30 | $21.80M | 1.26% |
| 2023-03-31 | $21.53M | -11.33% |
| 2022-12-31 | $24.28M | 12.46% |
| 2022-09-30 | $21.59M | -6.75% |
| 2022-06-30 | $23.15M | 9.24% |
| 2022-03-31 | $21.19M | -4.97% |
| 2021-12-31 | $22.30M | 22.30% |
| 2021-09-30 | $18.24M | 1.22% |
| 2021-06-30 | $18.02M | 7.22% |
| 2021-03-31 | $16.80M | 69.50% |
| 2020-12-31 | $9.91M | -48.60% |
| 2020-09-30 | $19.29M | 24.26% |
| 2020-06-30 | $15.52M | -28.72% |
| 2020-03-31 | $21.78M | 23.44% |
| 2019-12-31 | $17.64M | -30.14% |
| 2019-09-30 | $25.25M | -19.20% |
| 2019-06-30 | $31.26M | 24.70% |
| 2019-03-31 | $25.07M | 40.96% |
| 2018-12-31 | $17.78M | -2.74% |
| 2018-09-30 | $18.28M | -15.90% |
| 2018-06-30 | $21.74M | 11.24% |
| 2018-03-31 | $19.54M | 2.61% |
| 2017-12-31 | $19.04M | 11.28% |
| 2017-09-30 | $17.11M | 1.06% |
| 2017-06-30 | $16.93M | -9.65% |
| 2017-03-31 | $18.74M | 7.94% |
| 2016-12-31 | $17.36M | 2.44% |
| 2016-09-30 | $16.95M | -1.90% |
| 2016-06-30 | $17.28M | -2.61% |
| 2016-03-31 | $17.74M | 5.90% |
| 2015-12-31 | $16.75M | 1.29% |
| 2015-09-30 | $16.54M | -11.37% |
| 2015-06-30 | $18.66M | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | - |
Societal CDMO generated $27.72M in revenue during Q4 2023, up 17.50% compared to the previous quarter, and up 128.39% compared to the same period a year ago.
Societal CDMO Revenue Breakdown
Societal CDMO Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Mar 18 |
|---|---|
| Acute Care Segment | - |
| C D M O Segment | $19.54M |
Latest
Societal CDMO's latest quarterly revenue breakdown by segment (product or service), as of Mar 18: C D M O Segment (100.00%).
Societal CDMO Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 18 |
|---|---|
| C D M O Segment | $19.54M |
| Acute Care Segment | - |
Latest
Societal CDMO's latest quarterly revenue breakdown by geography, as of Mar 18: C D M O Segment (100.00%).
Societal CDMO Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PBH | Prestige Consumer Healthcare | $1.13B | $283.55M |
| PAHC | Phibro Animal Health | $977.89M | $273.16M |
| EVO | Evotec SE | $781.43M | $208.73M |
| SUPN | Supernus Pharmaceuticals | $607.52M | $175.69M |
| COLL | Collegium Pharmaceutical | $566.77M | $159.30M |
| ANIP | ANI Pharmaceuticals | $486.82M | $148.33M |
| PROC | Procaps Group | $409.92M | $118.41M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| DCPH | Deciphera Pharmaceuticals | $163.36M | $45.00M |
| SCTL | Societal CDMO | $94.64M | $27.72M |
| CPIX | Cumberland Pharmaceuticals | $39.55M | $9.09M |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
| IXHL | Incannex Healthcare | - | $12.00K |
| RGC | Regencell Bioscience | - | - |